Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 715,000 | 840,000 | 780,000 | 891,000 | 394,000 |
| Marketable Securities | 2,000 | 8,000 | 25,000 | 125,000 | N/A |
| Receivables | 253,000 | 233,000 | 341,000 | 351,000 | 479,000 |
| Inventories | 179,000 | 185,000 | 184,000 | 164,000 | 172,000 |
| Income taxes - deferred | 4,000 | N/A | 6,000 | 12,000 | 1,000 |
| Other current assets | 1,710,000 | 1,870,000 | 1,467,000 | 1,179,000 | 4,009,000 |
| TOTAL | $2,863,000 | $3,136,000 | $2,803,000 | $2,722,000 | $5,055,000 |
| Non-Current Assets | |||||
| PPE Net | 8,545,000 | 8,854,000 | 8,934,000 | 8,886,000 | 8,853,000 |
| Investments And Advances | 0 | 0 | 15,000 | 62,000 | 62,000 |
| Intangibles | 418,000 | 438,000 | 870,000 | 884,000 | 903,000 |
| Other Non-Current Assets | 1,714,000 | 1,703,000 | 1,591,000 | 1,648,000 | 1,655,000 |
| TOTAL | $10,677,000 | $10,995,000 | $11,410,000 | $11,480,000 | $11,473,000 |
| Total Assets | $13,540,000 | $14,131,000 | $14,213,000 | $14,202,000 | $16,528,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 191,000 | 158,000 | 303,000 | 323,000 | 412,000 |
| Accrued Expenses | 248,000 | 324,000 | 216,000 | 286,000 | 187,000 |
| TOTAL | $1,704,000 | $1,815,000 | $1,702,000 | $1,583,000 | $4,607,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,095,000 | 6,098,000 | 6,072,000 | 6,064,000 | 6,019,000 |
| Other Non-Current Liabilities | 766,000 | 804,000 | 788,000 | 558,000 | 905,000 |
| TOTAL | $7,912,000 | $8,136,000 | $8,026,000 | $7,940,000 | $7,841,000 |
| Total Liabilities | $9,616,000 | $9,951,000 | $9,728,000 | $9,523,000 | $12,448,000 |
| Shareholders' Equity | |||||
| Common Shares | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 |
| Retained earnings | -2,370,000 | -2,025,000 | -1,690,000 | -1,683,000 | -2,288,000 |
| Other shareholders' equity | -133,000 | -218,000 | -247,000 | -55,000 | -45,000 |
| TOTAL | $3,924,000 | $4,180,000 | $4,485,000 | $4,679,000 | $4,080,000 |
| Total Liabilities And Equity | $13,540,000 | $14,131,000 | $14,213,000 | $14,202,000 | $16,528,000 |